Back
Neogen Vs. Keros Therapeutics Industry Stock Comparison
Sell
40
NEOG
Neogen
Last Price:
15.62
Seasonality Move:
7.24%
Sell
27
KROS
Keros Therapeutics
Last Price:
45.71
Seasonality Move:
-4.71%
Sell
40
Neogen (NEOG)
is a Sell
Is Neogen a Buy, Sell or Hold?
- The current Neogen [NEOG] share price is $15.62. The Score for NEOG is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- NEOG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NEOG Stock Price Chart
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $45.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.
NEOG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.55 | Buy |
| Relative Strength Index (14 RSI): | 51.86 | Buy |
| Chaikin Money Flow: | -587901 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.11 - 16.95) | Buy |
| Bollinger Bands (100): | (12.92 - 16.68) | Buy |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.79 | Sell |
| Relative Strength Index (14 RSI): | 38.41 | Sell |
| Chaikin Money Flow: | 239305 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.72 - 49.1) | Sell |
| Bollinger Bands (100): | (49.87 - 64.91) | Sell |
NEOG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.27 | Sell |
| 20-day SMA: | 16.09 | Sell |
| 50-day SMA: | 14.04 | Buy |
| 200-day SMA: | 16.1 | Sell |
| 8-day EMA: | 16.12 | Sell |
| 20-day EMA: | 15.8 | Sell |
| 50-day EMA: | 14.99 | Buy |
| 200-day EMA: | 16.1 | Sell |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.61 | Buy |
| 20-day SMA: | 47.29 | Sell |
| 50-day SMA: | 51.65 | Sell |
| 200-day SMA: | 47.07 | Sell |
| 8-day EMA: | 45.93 | Sell |
| 20-day EMA: | 47.34 | Sell |
| 50-day EMA: | 50.89 | Sell |
| 200-day EMA: | 50 | Sell |
Neogen Earnings Growth & NEOG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.01 per share, and an increase next year of $0.09 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
Neogen Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||